A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study published online ...

Multidisciplinary care is a cornerstone of modern management for high- and very-high-risk cutaneous squamous cell carcinoma ...

Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...

Imaging is more sensitive than physical examination for nodal staging of cutaneous squamous cell carcinoma, according to a ...

Switching to sirolimus significantly reduces the risk of subsequent cSCC in high-risk kidney transplant recipients with history of the skin cancer. Switching kidney transplant recipients (KTRs) with ...

Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, arising from abnormal proliferation of epidermal keratinocytes due to chronic UV exposure. While highly curable (>90%) ...

What factors may put patients at an increased risk of cutaneous squamous cell carcinoma, and what should they know about ...